European Journal of Internal Medicine
Volume 23, Issue 4 , Pages 342-346 , June 2012

Evaluation of transient hyperglycemia in non-diabetic patients with febrile neutropenia

  • Dilek Ersil Soysal

      Affiliations

    • 1st Department of Internal Medicine, Ataturk Research and Training Hospital, Izmir, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 532 6832854.
    • ,
  • Volkan Karakus

      Affiliations

    • 1st Department of Internal Medicine, Ataturk Research and Training Hospital, Izmir, Turkey
    • ,
  • Ali Rıza Seren

      Affiliations

    • Department of Anesthesiology and Reanimation, Ataturk Research and Training Hospital, Izmir, Turkey
    • ,
  • Erhan Tatar

      Affiliations

    • 1st Department of Internal Medicine, Ataturk Research and Training Hospital, Izmir, Turkey
    • ,
  • Mustafa Celik

      Affiliations

    • Department of Gastroenterology, Ataturk Research and Training Hospital, Izmir, Turkey
    • ,
  • Sezin Hızar

      Affiliations

    • 1st Department of Internal Medicine, Ataturk Research and Training Hospital, Izmir, Turkey

Received 28 July 2011 ,Revised 14 December 2011 ,Accepted 20 December 2011.

References 

  1. Akova M, Akalın HE. Nötropenik hastalarda ates. Hacettepe Tıp Dergisi. 1988;21:71
  2. Bodey GP, Buckley M, Sathe YS, Freıreich EJ. Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64:328–340
  3. Glasmacher A, von Lilienfeld-Toal M, Schulte S, Hahn C, Schmidt-Wolf IGH, Prentice A. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients. Clin Microbiol Infect. 2005;11:17–23
  4. Klastersky J, Paesmans M, Rubenstein RB, Boyer M, Elting L, Feld R, et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18:3038–3051
  5. de Souza Viana L, Serufo JC, da Costa Rocha MO, Costa RN, Duarte RC. Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer. 2008;16:841–846
  6. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–982
  7. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553–591
  8. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798–1807
  9. Mehta KC. Stress hyperglycemia. Med Update. 2005;62:300–303
  10. American Diabetes Association . Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26:S33–S50
  11. Döşemeci L. Sepsis ve Kan Şekeri Kontrolü. ANKEM Derg. 2006;20:67–69
  12. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruynincxx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Eng J Med. 2001;345:1359–1367
  13. Ali AN, O'Brien JM, Blum W, Byrd JC, Klisovic RB, Marcucci G, et al. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer. 2007;110:96–102
  14. Saz EU, Ozen S, Simsek Goksen D, Darcan S. Stress hyperglycemia in febrile children: relationship to prediabetes. Minerva Endocrinol. 2011;36:99–105
  15. Marik PE, Murugan R. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30:748–756
  16. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–124

PII: S0953-6205(11)00317-7

doi: 10.1016/j.ejim.2011.12.010

European Journal of Internal Medicine
Volume 23, Issue 4 , Pages 342-346 , June 2012

Article Tools